Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5695561 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
There was no significant difference in groin recurrence or overall survival in those with or without GND in this population-based cohort, raising questions whether a subgroup of patients may not benefit from GND. Patients had a higher probability of dying before groin recurrence could occur. Future trial design should consider death as a competing risk.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Lilian T. Gien, Rinku Sutradhar, Gillian Thomas, Allan Covens, Laurie Elit, Eileen Rakovitch, Anthony Fyles, Mahmoud A. Khalifa, Ying Liu, Lisa Barbera,